Choose License Type
The global spirometer market was valued at USD 833.4 million in 2019 and is expected to grow at a CAGR of 10.9% over the forecast period. Increasing air pollution levels coupled with changes in the environment have dramatically increased the burden of respiratory diseases, thereby boosting demand for pulmonary tests. Spirometer facilitates accurate diagnosis of respiratory disorders including bronchitis, asthma, emphysema, and COPD. It also allows for the monitoring of exposure to chemicals at work, the effect of medicine, shortness of breath, lung function before surgery and improvement in the treatment of diseases. The above benefits are anticipated to fuel market growth over the forecast period.
The global spirometer market is categorized based on product, mechanism, application, and end user. Region wise, North America was the largest market in 2019; however, Asia Pacific is expected to be the fastest growing region by 2028 owing to rising healthcare and medical device industry across the region.
Key players serving the global spirometer market include Koninklijke Philips N.V., Teleflex Incorporated, MGC Diagnostics Corporation, Smiths Medical, Welch Allyn, VYAIRE, Hillrom, Sibelmed, FUKUDA SANGYO CO., LTD, SCHILLER AG among other prominent players.
Key segments of the global spirometer market
Product Overview, 2018-2028 (USD Million)
Mechanism Overview, 2018-2028 (USD Million)
Application Overview, 2018-2028 (USD Million)
End User Overview, 2018-2028 (USD Million)
Regional Overview, 2018-2028 (USD Million)
Reasons for the study
What does the report include?
Who should buy this report?
Consultants, analysts, researchers, and academicians looking for insights shaping the global spirometer market
The prevalence of COPD is constantly increasing due to rising air pollution levels and changes in the environment. COPD represents the world's second-most frequent lung disorder. Around 4 million premature deaths result from chronic respiratory illnesses. More than 830,000 people were diagnosed with COPD in the year 2011 according to the U.S. Department of Health. Over the past decade, there has been approximately 27% increase in the number of people diagnosed. COPD represents the world's second-most frequent lung disorder. Moreover, the worsening levels of air pollution and environmental conditions are creating additional cases of asthma. Hence, all these factors are anticipated to fuel global spirometers market growth over the forecast period.
The global spirometer market has been segmented based on Product, Mechanism, Application, and End User. Based on the application, the global spirometers market is bifurcated into asthma, COPD, cystic fibrosis, pulmonary fibrosis, and other applications. As per our research study, COPD dominated the global spirometers market in 2019 whereas Asthma segment is projected to witness the fastest growth rate from 2020 to 2028. As per the report of the World Health Organization, approximately 65 million people are currently suffering from mild to severe COPD globally.
In the year 2019, hospitals & clinics held the majority of the global spirometer market share based on the end-user segment owing to rising usage of spirometry in hospital & clinics sector. Additionally, home healthcare segment is projected to witness the highest growth rate from 2020 to 2028 owing to rising preference for respiratory diseases management at home.
Based on regions, the global spirometer market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. In the year 2019, North America held the majority of the market share owing to the presence of large patient pool suffering from numerous respiratory conditions. On the other hand, Asia Pacific region is anticipated to witness highest growth rate owing to rising demand for spirometers from emerging economies such as Japan, China, and India. Asia Pacific spirometers market is dominated by China, and followed by China, and India. India spirometers market is projected to witness fastest growth rate owing to rising healthcare awareness coupled with growing government focus to develop healthcare and medical device industry for the growing population.
The global spirometer market was valued at USD 833.4 million in 2019 and is expected to grow at a CAGR of 10.9% over the forecast period. Increasing air pollution levels coupled with changes in the environment have dramatically increased the burden of respiratory diseases, thereby boosting demand for pulmonary tests. Spirometer facilitates accurate diagnosis of respiratory disorders including bronchitis, asthma, emphysema, and COPD. It also allows for the monitoring of exposure to chemicals at work, the effect of medicine, shortness of breath, lung function before surgery and improvement in the treatment of diseases. The above benefits are anticipated to fuel market growth over the forecast period.
The global spirometer market is categorized based on product, mechanism, application, and end user. Region wise, North America was the largest market in 2019; however, Asia Pacific is expected to be the fastest growing region by 2028 owing to rising healthcare and medical device industry across the region.
Key players serving the global spirometer market include Koninklijke Philips N.V., Teleflex Incorporated, MGC Diagnostics Corporation, Smiths Medical, Welch Allyn, VYAIRE, Hillrom, Sibelmed, FUKUDA SANGYO CO., LTD, SCHILLER AG among other prominent players.
Key segments of the global spirometer market
Product Overview, 2018-2028 (USD Million)
Mechanism Overview, 2018-2028 (USD Million)
Application Overview, 2018-2028 (USD Million)
End User Overview, 2018-2028 (USD Million)
Regional Overview, 2018-2028 (USD Million)
Reasons for the study
What does the report include?
Who should buy this report?
Consultants, analysts, researchers, and academicians looking for insights shaping the global spirometer market
Chapter 1. Introduction
1.1. Introduction to the Study
1.2. Market Definition and Scope
1.3. Units, Currency, Conversions and Years Considered
1.4. Key Stakeholders
1.5. Key Questions Answered
Chapter 2. Research Methodology
2.1. Introduction
2.2. Data Capture Sources
2.3. Primary Sources
2.4. Secondary Sources
2.5. Market Size Estimation
2.6. Market Forecast
2.7. Data Triangulation
2.8. Assumptions and Limitations
Chapter 3. Market Outlook
3.1. Introduction
3.2. Macroeconomic Indicators
3.3. Market Dynamics
3.3.1. Drivers
3.3.2. Restraints
3.3.3. Opportunities
3.3.4. Challenges
3.4. Porter’s Five Forces Analysis
3.5. PESTLE Analysis
3.6. COVID-19 Impact Analysis
Chapter 4. Global Spirometer Market by Product, 2018-2028 (USD Million)
4.1.1. Device
4.1.2. Consumables and Accessories
4.1.3. Software
Chapter 5. Global Spirometer Market by Mechanism, 2018-2028 (USD Million)
5.1.1. Flow Sensor
5.1.2. Peak Flow Meter
Chapter 6. Global Spirometer Market by Application, 2018-2028 (USD Million)
6.1.1. COPD
6.1.2. Asthma
6.1.3. Cystic Fibrosis
6.1.4. Pulmonary Fibrosis
6.1.5. Others
Chapter 7. Global Spirometer Market by End User, 2018-2028 (USD Million)
7.1.1. Hospitals & Clinics
7.1.2. Home Healthcare
Chapter 8. Global Spirometer Market by Region, 2018-2028 (USD Million)
8.1. North America
8.1.1. U.S.
8.1.2. Canada
8.2. Europe
8.2.1. Germany
8.2.2. UK
8.2.3. France
8.2.4. Spain
8.2.5. Rest of Europe
8.3. Asia Pacific
8.3.1. Japan
8.3.2. China
8.3.3. India
8.3.4. Rest of Asia Pacific
8.4. Latin America
8.4.1. Brazil
8.4.2. Mexico
8.4.3. Rest of Latin America
8.5. Middle East and Africa
8.5.1. GCC
8.5.2. South Africa
8.5.3. Rest of Middle East and Africa
Chapter 9. Company Profiles
9.1. Koninklijke Philips N.V.
9.1.1. Overview
9.1.2. Products and Services Portfolio
9.1.3. Recent Initiatives
9.1.4. Company Financials
9.2. Teleflex Incorporated
9.2.1. Overview
9.2.2. Products and Services Portfolio
9.2.3. Recent Initiatives
9.2.4. Company Financials
9.3. MGC Diagnostics Corporation
9.3.1. Overview
9.3.2. Products and Services Portfolio
9.3.3. Recent Initiatives
9.3.4. Company Financials
9.4. Smiths Medical
9.4.1. Overview
9.4.2. Products and Services Portfolio
9.4.3. Recent Initiatives
9.4.4. Company Financials
9.5. Welch Allyn
9.5.1. Overview
9.5.2. Products and Services Portfolio
9.5.3. Recent Initiatives
9.5.4. Company Financials
9.6. VYAIRE
9.6.1. Overview
9.6.2. Products and Services Portfolio
9.6.3. Recent Initiatives
9.6.4. Company Financials
9.7. Hillrom
9.7.1. Overview
9.7.2. Products and Services Portfolio
9.7.3. Recent Initiatives
9.7.4. Company Financials
9.8. Sibelmed
9.8.1. Overview
9.8.2. Products and Services Portfolio
9.8.3. Recent Initiatives
9.8.4. Company Financials
9.9. FUKUDA SANGYO CO., LTD
9.9.1. Overview
9.9.2. Products and Services Portfolio
9.9.3. Recent Initiatives
9.9.4. Company Financials
9.10. SCHILLER AG
9.10.1. Overview
9.10.2. Products and Services Portfolio
9.10.3. Recent Initiatives
9.10.4. Company Financials
Chapter 10. Appendix
10.1. Primary Research Approach
10.1.1. Primary Interview Participants
10.1.2. Primary Interview Summary
10.2. Questionnaire
10.3. Related Reports
10.3.1. Published
10.3.2. Upcoming